SCHEMBL2735379

SCHEMBL2735379

O=C(Nc1ccccc1)C(O)CCO

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 1/20 0.59
ALDH1A1 P00352 5/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
GAA P10253 3/20 0.53
POLB P06746 1/20 0.52
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 5/20 0.47
ATM Q13315 2/20 0.47
LMNA P02545 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
EPHX2 P34913 2/20 0.47
TP53 P04637 1/20 0.47
EPHX1 P07099 1/20 0.47
TSHR P16473 1/20 0.47
CDK9 P50750 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
HSP90AA1 P07900 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28548192 0.85 POLB (0.55) HDAC2ALDH1A1SMN1; SMN2GAAPOLB
SCHEMBL16964230 0.84 HDAC2 (0.57) HDAC2ALDH1A1SMN1; SMN2GAAPOLB
SCHEMBL7102450 0.81 HDAC2 (0.58) HDAC2ALDH1A1SMN1; SMN2GAAPOLB
SCHEMBL10067641 0.80 MME (0.59) ALDH1A1SMN1; SMN2GAAPOLBMEN1
SCHEMBL27709662 0.80 ALDH1A1 (0.54) HDAC2ALDH1A1SMN1; SMN2GAAPOLB
SCHEMBL21477715 0.80 ALDH1A1 (0.47) HDAC2ALDH1A1SMN1; SMN2GAAPOLB
SCHEMBL21477716 0.80 ALDH1A1 (0.47) HDAC2ALDH1A1SMN1; SMN2GAAPOLB
SCHEMBL4594451 0.79 MEN1 (0.62) HDAC2ALDH1A1SMN1; SMN2GAAPOLB
SCHEMBL28022968 0.79 POLB (0.53) HDAC2ALDH1A1SMN1; SMN2GAAPOLB
SCHEMBL4888030 0.79 ROCK1 (0.54) HDAC2ALDH1A1SMN1; SMN2GAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2220080-B1 HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2012-01-04 EP disclosed
EP-2231655-B1 4(-3-(-2-(PHENYL)MORPHOLINO)-2-OXOPYRROLIDIN-1-YL)-N-(THIAZOL-2-YL)BENZENESULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF ION CHANNELS FOR THE TREATMENT OF PAIN VERTEX PHARMA (US) 2011-08-31 EP disclosed
WO-2009064752-A2 HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-05-22 WO disclosed
WO-2009064747-A2 4(-3-(-2-(PHENYL)MORPHOLINO)-2-OXOPYRROLIDIN-1-YL)-N-(THIAZOL-2-YL)BENZENESULFONAMIDE DERIVATI VES AND RELATED COMPOUNDS AS MODULATORS OF ION CHANNELS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-05-22 WO disclosed